TMO - Thermo Fisher Scientific Inc.

NYSE - NYSE Delayed price. Currency in USD
Currency in USD

Valuation measures4

Market cap (intra-day) 200.88B
Enterprise value 232.65B
Trailing P/E 33.95
Forward P/E 21.88
PEG ratio (5-yr expected) 3.84
Price/sales (ttm)4.66
Price/book (mrq)4.75
Enterprise value/revenue 5.31
Enterprise value/EBITDA 21.29

Trading information

Stock price history

Beta (5Y monthly) 0.79
52-week change 3-3.53%
S&P500 52-week change 36.21%
52-week high 3611.06
52-week low 3475.77
50-day moving average 3546.92
200-day moving average 3546.37

Share statistics

Avg vol (3-month) 31.45M
Avg vol (10-day) 32.14M
Shares outstanding 5385.72M
Implied shares outstanding 6N/A
Float 8384.94M
% held by insiders 10.19%
% held by institutions 192.51%
Shares short (14 May 2023) 43.01M
Short ratio (14 May 2023) 41.87
Short % of float (14 May 2023) 40.78%
Short % of shares outstanding (14 May 2023) 40.78%
Shares short (prior month 13 Apr 2023) 42.95M

Dividends & splits

Forward annual dividend rate 41.4
Forward annual dividend yield 40.27%
Trailing annual dividend rate 31.25
Trailing annual dividend yield 30.24%
5-year average dividend yield 40.22
Payout ratio 48.15%
Dividend date 313 Jul 2023
Ex-dividend date 413 Jun 2023
Last split factor 23:2
Last split date 305 Jun 1996

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2022
Most-recent quarter (mrq)31 Mar 2023


Profit margin 13.75%
Operating margin (ttm)17.05%

Management effectiveness

Return on assets (ttm)4.98%
Return on equity (ttm)14.44%

Income statement

Revenue (ttm)43.81B
Revenue per share (ttm)112.18
Quarterly revenue growth (yoy)-9.40%
Gross profit (ttm)19B
Net income avi to common (ttm)6.02B
Diluted EPS (ttm)15.33
Quarterly earnings growth (yoy)-41.80%

Balance sheet

Total cash (mrq)3.48B
Total cash per share (mrq)9.03
Total debt (mrq)35.34B
Total debt/equity (mrq)83.28
Current ratio (mrq)1.27
Book value per share (mrq)109.55

Cash flow statement

Operating cash flow (ttm)7.68B
Levered free cash flow (ttm)4.6B